NeuroTIX Co., Ltd. (CEO Kim Dong-ju) announced that it will participate in CES 2024, the world’s largest IT and home appliance exhibition, to be held in Las Vegas, USA in January next year.
NeuroTIX is an electronic medicine company with expertise in autonomic nervous system control technology using artificial intelligence. We are developing a wellness platform in the form of medical devices and consumer electronic medicines that manage autonomic nervous system symptoms in diseases, and to this end, we are continuing extensive research and development cooperation with major domestic hospitals and medical research institutes.
Their technology is tailored to each patient’s needs and works by promoting the release of specific neurotransmitters and activation of anti-inflammatory pathways. The company explains that this approach can be applied to a variety of neuropsychiatric medical disorders, from sleep disorders to acquired brain damage and early stages of neurodegeneration.
At this CES, NeurotX will introduce its wellness device, ‘SleepAid-P’. This is a product that provides customized sleep management functions for patients who have difficulty sleeping. It monitors and analyzes the user’s movements and physiological state during sleep using onboard sensors and neurofeedback machine learning technology.
Based on the collected data, SleepAid-P delivers customized stimulation to the user’s vagus nerve to safely and effectively promote sleep, and can also be expected to improve sleep quality. In addition, it is manufactured in the form of a wearable patch, minimizing discomfort while wearing it and allowing you to regularly use the easy sleep management function without any hassle.
NeuroTIX said, “SleepAid-P, which is planned to be launched in domestic and overseas markets after CES 2024, is a product for everyone suffering from absolute sleep deprivation and chronic poor sleep quality,” adding, “At the same time, it is the first step in our wellness device business.” “As it is a product, it will play a big role in determining NeuroTIX’s awareness and position in the global market in the future,” he said.
“Along with SleepAid-P, our company is also developing ‘SleepAid-M,’ a medical-grade sleep management device,” he said. “In this way, beyond a device for managing sleep disorders, we are also developing chronic pain management, relief of depression and anxiety symptoms, and post-intensive care syndrome.” “We aim to realize the company’s pipeline by commercializing a variety of products and platforms for specialized purposes such as management,” he emphasized.
Meanwhile, ‘CES’, the world’s largest IT exhibition hosted by the Consumer Technology Association (CTA), is an exhibition that provides a glimpse into the flow of innovative technologies around the world and is held every January in Las Vegas, USA. AVING News, which has covered CES for 18 consecutive years, has reported CES news around the world every year since 2006, and has been selected through ‘BEST OF CES’ and ‘BEST OF MADE IN KOREA’, which select the best innovative products, companies and technologies. has been in progress. In addition, CES on-site issues are vividly conveyed through ‘AVING LIVE’.
The CES 2024 Seoul Unified Hall will be operated at the largest scale in terms of exhibition area, number of participating companies, and number of participating supporters since Seoul City’s first participation in CES in 2020. The Seoul Integration Center, in which 13 organizations collaborate and participate, is an important step in Seoul’s efforts to make Seoul a mecca for startups, and 17 of the companies participating in the Seoul Integration Center proved this by receiving innovation awards. The participating institutions in the Seoul Unification Center are ▲SBA ▲Seoul Bio Hub ▲Campus Town ▲AI Yangjae Hub ▲Gwanak-gu ▲Yonsei University ▲Korea University ▲Chung-Ang University ▲Sogang University ▲Kookmin University ▲Hanyang University ▲Konkuk University ▲Kyunghee University. Not only the Seoul Metropolitan Government, institutions, and companies, but also supporters through industry-academia cooperation are matched 1:1 with companies, and 85 supporters, the largest number, will participate.
* Special reporters: Joseph Choe, Kidai Kim, Dongkwan Kim, Mokkyung Lee, Sangun Choi, Seung Hyun Nam, Sunghwan Kim, Taeuck Lim, Min Choi